Shahram Habibzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shahram Habibzadeh has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
- Nasrollah Maleki
Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
7 shared publications - Abbas Yazdanbod
Digestive Disease Research Center, Ardabil University of Medical Sciences, Ardabil, Iran
3 shared publications - Mohsen Arzanlou
Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran
3 shared publications Afshin Hooshyar
Department of Internal Medicine, Imam Khomeini Hospital, Ardabil University of Medical Sciences, Ardabil, Iran
2 shared publications- Ali Jafari-Khounigh
Road Traffic Injury Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Alireza Razzaghi
Qazvin University of Medical Sciences
2 shared publications
Latest Publications
- 31 March 2025
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 14  (1)
Personal preventive protocols and travel patterns during the COVID-19 pandemic
Background — Travel restrictions and adhering to health protocols while traveling was among the key strategies to combat COVID-19 pandemic. Objective — The present study aims to measure and evaluate travel patterns and compliance with COVID-19 prevention protocols during traveling. Methods — In this cross-sectional study, 589 individuals from the capitals of six provinces of Iran were included in the study using the cluster sampling method. There were 40 clusters. For data analysis, the mean value of responses in each individual was calculated for each section of the questionnaire. Results — The response rate was 92% (589/640). Of all participants, 309 (52.5%) were women. The mean age of study participants was 42.84 years (SD=16.59). Among participants, 355 (60.3%) had a travel history during the COVID-19 pandemic. We revealed statistically significant relationships of the travel history with age (P<0.001), education level (P<0.001), and province (P0.05). The majority of study participants (38.5%) traveled for recreational purposes. Conclusion: According to our findings, unnecessary travel was not avoided in Iran during the COVID-19 pandemic. Most of the participants who traveled during the COVID-19 pandemic did not follow safety precautions. Thus, some of the most important issues such as cultural influences, different risk tolerance levels among people, law enforcement, and stricter oversight by decision makers need to be taken into account.
- 31 March 2025
- Published by LLC Science and Innovations in Russian Open Medical Journal
- Vol. 14  (1)
Personal preventive protocols and travel patterns during the COVID-19 pandemic
Background — Travel restrictions and adhering to health protocols while traveling was among the key strategies to combat COVID-19 pandemic. Objective — The present study aims to measure and evaluate travel patterns and compliance with COVID-19 prevention protocols during traveling. Methods — In this cross-sectional study, 589 individuals from the capitals of six provinces of Iran were included in the study using the cluster sampling method. There were 40 clusters. For data analysis, the mean value of responses in each individual was calculated for each section of the questionnaire. Results — The response rate was 92% (589/640). Of all participants, 309 (52.5%) were women. The mean age of study participants was 42.84 years (SD=16.59). Among participants, 355 (60.3%) had a travel history during the COVID-19 pandemic. We revealed statistically significant relationships of the travel history with age (P<0.001), education level (P<0.001), and province (P0.05). The majority of study participants (38.5%) traveled for recreational purposes. Conclusion: According to our findings, unnecessary travel was not avoided in Iran during the COVID-19 pandemic. Most of the participants who traveled during the COVID-19 pandemic did not follow safety precautions. Thus, some of the most important issues such as cultural influences, different risk tolerance levels among people, law enforcement, and stricter oversight by decision makers need to be taken into account.
- Open Access
- 18 February 2025
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 13  (1) , 34519
WHO survey tool for behavioral insights on COVID-19: A psychometric study for translation, adaptation and content validity in Persian
Introduction: Different instruments are employed to assess public behavior and understanding of COVID-19. The World Health Organization Survey Tool for Behavioral Insights on COVID-19 (WHO-STBIC) is an appealing and adaptable instrument for evaluating population behavioral insights. This research sought to translate, adapt, and content validate the Persian version of WHO-STBIC. Methods: Forward-backward translation of the English WHO-STBIC to Persian was done by four English language experts. The back-translated version was compared with the original version and disagreements were resolved by a team encompassing four translators and two experts in the field. To investigate the content validity of the preliminary Persian version, nine experts were invited to assess the tool through a content validity form. The internal consistency was evaluated using Cronbach’s alpha. Results: A shortened through adaptation version Persian version of WHO-STBIC (90 items in 17 subscales) was derived with minor adaptations from the original version. In terms of content validity, the modified kappa (mK) index was calculated as excellent for 86 percent (n=78) of items (mK>0.9). The mean Content validity Index (CVI) of the whole scale was 0.87 ranging from 0.46 to 0.86 for 17 subscales. Cronbach’s alpha was calculated to be 0.86. Conclusion: The Persian version of WHO-STBIC was adapted and validated with minimum modifications to be used in Iran. It was hard to say that this tool is a fast one. So, the shortened through adaptation Persian version was developed. Researchers can use these tools to ensure culturally appropriate, relevant, valid, and reliable data collection.
- 18 February 2025
- Published by Maad Rayan Publishing Company in Journal of Research in Clinical Medicine
- Vol. 13  (1) , 34519
Open AccessWHO survey tool for behavioral insights on COVID-19: A psychometric study for translation, adaptation and content validity in Persian
Introduction: Different instruments are employed to assess public behavior and understanding of COVID-19. The World Health Organization Survey Tool for Behavioral Insights on COVID-19 (WHO-STBIC) is an appealing and adaptable instrument for evaluating population behavioral insights. This research sought to translate, adapt, and content validate the Persian version of WHO-STBIC. Methods: Forward-backward translation of the English WHO-STBIC to Persian was done by four English language experts. The back-translated version was compared with the original version and disagreements were resolved by a team encompassing four translators and two experts in the field. To investigate the content validity of the preliminary Persian version, nine experts were invited to assess the tool through a content validity form. The internal consistency was evaluated using Cronbach’s alpha. Results: A shortened through adaptation version Persian version of WHO-STBIC (90 items in 17 subscales) was derived with minor adaptations from the original version. In terms of content validity, the modified kappa (mK) index was calculated as excellent for 86 percent (n=78) of items (mK>0.9). The mean Content validity Index (CVI) of the whole scale was 0.87 ranging from 0.46 to 0.86 for 17 subscales. Cronbach’s alpha was calculated to be 0.86. Conclusion: The Persian version of WHO-STBIC was adapted and validated with minimum modifications to be used in Iran. It was hard to say that this tool is a fast one. So, the shortened through adaptation Persian version was developed. Researchers can use these tools to ensure culturally appropriate, relevant, valid, and reliable data collection.
- 20 October 2023
- Published by Springer Nature in Current Microbiology
- Vol. 80  (12) , 1-10
Adverse Effects Reported and Insights Following Sinopharm COVID-19 Vaccination
Vaccines are promising strategies for controlling COVID-19; however, COVID-19 vaccine side effects play a central role in public confidence in the vaccine and its uptake process. This study aimed to provide evidence on the post-vaccination early side effects of the BBIBP-CorV (Sinopharm) vaccine. This cross-sectional survey-based study was conducted between November 2021 and January 2022 among recipients of the BBIBP-CorV vaccine, using a questionnaire-based survey. Our final sample consisted of 657 participants, including 392 women. Among the study cases, only 103 (15.7%) participants received one dose of vaccine, and the rest received both doses (N = 554, 84.3%). Systemic symptoms (first dose: N = 187, both doses: N = 128) were the most commonly reported events after vaccination, and among them, injection site pain (first dose: 19.3%, both doses: 12.9%) was the most prevalent adverse effect. All reporting events were mild and resolved in less than 3 days without hospitalization. Among the participants, females and young people aged 35–65 were more prone to manifest side effects (N = 169, 53.3%) after the vaccine injection. Furthermore, our results revealed that the recipients who were suffering from underlying diseases, including diabetes, renal disorder, and respiratory illness, reported fewer adverse responses after vaccination in comparison with healthy individuals. Vaccination against SARS-CoV-2 may lead to some adverse reactions in recipients. However, the frequency of post-vaccination early side effects differed in people, but all responses were slight and temporary.
- 20 October 2023
- Published by Springer Nature in Current Microbiology
- Vol. 80  (12) , 1-10
Adverse Effects Reported and Insights Following Sinopharm COVID-19 Vaccination
Vaccines are promising strategies for controlling COVID-19; however, COVID-19 vaccine side effects play a central role in public confidence in the vaccine and its uptake process. This study aimed to provide evidence on the post-vaccination early side effects of the BBIBP-CorV (Sinopharm) vaccine. This cross-sectional survey-based study was conducted between November 2021 and January 2022 among recipients of the BBIBP-CorV vaccine, using a questionnaire-based survey. Our final sample consisted of 657 participants, including 392 women. Among the study cases, only 103 (15.7%) participants received one dose of vaccine, and the rest received both doses (N = 554, 84.3%). Systemic symptoms (first dose: N = 187, both doses: N = 128) were the most commonly reported events after vaccination, and among them, injection site pain (first dose: 19.3%, both doses: 12.9%) was the most prevalent adverse effect. All reporting events were mild and resolved in less than 3 days without hospitalization. Among the participants, females and young people aged 35–65 were more prone to manifest side effects (N = 169, 53.3%) after the vaccine injection. Furthermore, our results revealed that the recipients who were suffering from underlying diseases, including diabetes, renal disorder, and respiratory illness, reported fewer adverse responses after vaccination in comparison with healthy individuals. Vaccination against SARS-CoV-2 may lead to some adverse reactions in recipients. However, the frequency of post-vaccination early side effects differed in people, but all responses were slight and temporary.
- Open Access
- 25 August 2022
- Published by Wolters Kluwer Health in Journal of Education and Health Promotion
- Vol. 11  (1) , 266
The effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
BACKGROUND: Infection with COVID-19 has resulted in considerable mortality all around the world. This study aimed to investigate the effect of convalescent plasma on the treatment of hospitalized patients with COVID-19 in Imam Khomeini Hospital at Ardabil, Iran. MATERIALS AND METHODS: In this quasi-experimental clinical trial, patients over 18 years of age with polymerase chain reaction-positive COVID-19 were admitted based on the clinical criteria of respiratory distress with hypoxia (O 2 saturation 24) with moderate-to-severe lung involvement and in the 1 st week of respiratory disease who were not intubated were nonrandomly assigned to two groups: convalescent plasma therapy (CPT) group (197 cases) and control group (200 cases). We used the Chi-square, t-test, Fisher's exact test, and Pearson's correlation coefficient for statistical analysis. RESULTS: Analyses revealed that length of stay in hospital was significantly lower in the CPT group as compared to the control group ( P = 0.001). Twenty-four cases (22.0%) in the CPT group and 85 cases (78.0%) in the control group needed intubation. Furthermore, mortality was 17 cases (18.3%) in the CPT group and 76 cases (81.7%) in the control group, the difference of which was also found to be statistically significant ( P < 0.05). CONCLUSIONS: It seems that CPT can be used as an alternative treatment at the early stages of COVID-19 to prevent the progress of the disease, reduce the need for intubation and consequently the length of stay in hospital, and finally, decrease mortality.
- 25 August 2022
- Published by Wolters Kluwer Health in Journal of Education and Health Promotion
- Vol. 11  (1) , 266
Open AccessThe effect of convalescent plasma on the treatment of COVID-19 patients in Ardabil, Iran
BACKGROUND: Infection with COVID-19 has resulted in considerable mortality all around the world. This study aimed to investigate the effect of convalescent plasma on the treatment of hospitalized patients with COVID-19 in Imam Khomeini Hospital at Ardabil, Iran. MATERIALS AND METHODS: In this quasi-experimental clinical trial, patients over 18 years of age with polymerase chain reaction-positive COVID-19 were admitted based on the clinical criteria of respiratory distress with hypoxia (O 2 saturation 24) with moderate-to-severe lung involvement and in the 1 st week of respiratory disease who were not intubated were nonrandomly assigned to two groups: convalescent plasma therapy (CPT) group (197 cases) and control group (200 cases). We used the Chi-square, t-test, Fisher's exact test, and Pearson's correlation coefficient for statistical analysis. RESULTS: Analyses revealed that length of stay in hospital was significantly lower in the CPT group as compared to the control group ( P = 0.001). Twenty-four cases (22.0%) in the CPT group and 85 cases (78.0%) in the control group needed intubation. Furthermore, mortality was 17 cases (18.3%) in the CPT group and 76 cases (81.7%) in the control group, the difference of which was also found to be statistically significant ( P < 0.05). CONCLUSIONS: It seems that CPT can be used as an alternative treatment at the early stages of COVID-19 to prevent the progress of the disease, reduce the need for intubation and consequently the length of stay in hospital, and finally, decrease mortality.
- Open Access
- 8 February 2022
- Published by Bentham Science Publishers Ltd. in The Open Public Health Journal
- Vol. 15  (1)
Seroprevalence of SARS-CoV-2 Antibodies and its Risk Factors in the North-West of Iran: A Population-Based Cross-Sectional Study
Background: The aim of this study is to determine the prevalence of SARS-CoV-2 seropositivity and to examine the risk factors for seropositivity among the people of Ardabil, in the northwestern part of Iran. Methods: A community-based survey was carried out involving 1013 participants (690 from urban and 323 from rural areas), who were selected based on the cluster sampling method. Iran’s FDA-approved Pishtaz Teb SARS-CoV-2 ELISA kits were used to assess the presence of SARS-CoV-2-specific immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in serum samples. Weighted seroprevalence, the number of infections, infection to case ratio (ICR), and infection fatality ratio (IFR) were estimated after adjusting for survey design and serial test performance. The factors associated with IgG/IgM positive were determined using logistic regression. Results: Between May 20 and June 7, out of 1013 survived people, 123 (12.11%) were IgG positive, 49 (4.8%) were IgM positive and 122 (12.04%) were having both IgG and IgM antibodies. The highest frequency of positive test for IgG and IgM antibodies was found in people with diabetes, followed by people with obesity and heart disease, respectively. Multivariate logistic regression showed old age (2.04, 95% CI: 1.02 to 11.74), male sex (1.52, 95% CI: 1.15 to 2.13), urbanization (1.40, 95% CI: 1.02 to 3.22), higher family number (9.44, 95% CI: 1.69 to 52.13), obesity (2.14, 95% CI: 1.11 to 5.86), NCDs (1.22, 95% CI: 1.01 to 2.16), having symptoms (3.02, 95% CI: 1.64 to 8.61), traveling (2.70, 95% CI: 1.76 to 10.8), history of contact with infected patients (2.38, 95% CI: 1.08 to 7.03), as factors associated with IgG/IgM positive test. Conclusion: Around the mid of May 2020, SARS-CoV-2 seroprevalence was low among Ardabil's adult population. Several factors have been found to be associated with SARS-CoV-2 seroprevalence, which should be considered by policymakers to set policies against the SARS-CoV-2 pandemic.
- 8 February 2022
- Published by Bentham Science Publishers Ltd. in The Open Public Health Journal
- Vol. 15  (1)
Open AccessSeroprevalence of SARS-CoV-2 Antibodies and its Risk Factors in the North-West of Iran: A Population-Based Cross-Sectional Study
Background: The aim of this study is to determine the prevalence of SARS-CoV-2 seropositivity and to examine the risk factors for seropositivity among the people of Ardabil, in the northwestern part of Iran. Methods: A community-based survey was carried out involving 1013 participants (690 from urban and 323 from rural areas), who were selected based on the cluster sampling method. Iran’s FDA-approved Pishtaz Teb SARS-CoV-2 ELISA kits were used to assess the presence of SARS-CoV-2-specific immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies in serum samples. Weighted seroprevalence, the number of infections, infection to case ratio (ICR), and infection fatality ratio (IFR) were estimated after adjusting for survey design and serial test performance. The factors associated with IgG/IgM positive were determined using logistic regression. Results: Between May 20 and June 7, out of 1013 survived people, 123 (12.11%) were IgG positive, 49 (4.8%) were IgM positive and 122 (12.04%) were having both IgG and IgM antibodies. The highest frequency of positive test for IgG and IgM antibodies was found in people with diabetes, followed by people with obesity and heart disease, respectively. Multivariate logistic regression showed old age (2.04, 95% CI: 1.02 to 11.74), male sex (1.52, 95% CI: 1.15 to 2.13), urbanization (1.40, 95% CI: 1.02 to 3.22), higher family number (9.44, 95% CI: 1.69 to 52.13), obesity (2.14, 95% CI: 1.11 to 5.86), NCDs (1.22, 95% CI: 1.01 to 2.16), having symptoms (3.02, 95% CI: 1.64 to 8.61), traveling (2.70, 95% CI: 1.76 to 10.8), history of contact with infected patients (2.38, 95% CI: 1.08 to 7.03), as factors associated with IgG/IgM positive test. Conclusion: Around the mid of May 2020, SARS-CoV-2 seroprevalence was low among Ardabil's adult population. Several factors have been found to be associated with SARS-CoV-2 seroprevalence, which should be considered by policymakers to set policies against the SARS-CoV-2 pandemic.
- 1 February 2018
- Published by Elsevier in Virus Research
- Vol. 245, 29-43
Current concepts on immunopathogenesis of hepatitis B virus infection
- 1 February 2018
- Published by Elsevier in Virus Research
- Vol. 245, 29-43
Current concepts on immunopathogenesis of hepatitis B virus infection
- Open Access
- 1 December 2017
- Vol. 11  (4) , 482-496
Situational Analysis of Visceral Leishmaniasis in the Most Important Endemic Area of the Disease in Iran
Background: Visceral leishmaniasis is one of the most important vector borne diseases in the world, transmitted by sand flies. Despite efforts to prevent the spread of the disease, cases continue worldwide. In Iran, the disease usually occurs in children under 10 years. In the absence of timely diagnosis and treatment, the mortality rate is 95-100%. The main objective of this study was to determine the spatial and temporal distribution of visceral leishmaniasis as well as its correlation with climatic factors for determining high-risk areas in an endemic focus in northwestern Iran. Methods: In this cross-sectional study, data on VL cases were collected from local health centers in Ardabil Province, Iran during 2001-2015 to establish a geodatabase using ArcGIS10.3. Data analysis was conducted using SPSS23 and ArcMap Spatial Analyst. MaxEnt model was used to determine ecologically suitable nichesfor the disease. Results: Two hotspots were found in Meshkinshahr and Germi counties with 59% and 23% of total cases, respectively. There was an increase in the incidence rate of VL in Ardabil County from 2.9 in 2009 to 9.2/ 100,000 population in 2015. There was no spatial autocorrelation between county and total number of cases (P> 0.05). Higher NDVI, lower altitude and southern aspects had positive effects on the presence probability of VL. Conclusion: The number of cases of this disease have been rising since 2013 and doubled in 2015. According to the derived distribution maps, the disease is spreading to new locations such as Ardabil and Namin counties.
- 1 December 2017
- Vol. 11  (4) , 482-496
Open AccessSituational Analysis of Visceral Leishmaniasis in the Most Important Endemic Area of the Disease in Iran
Background: Visceral leishmaniasis is one of the most important vector borne diseases in the world, transmitted by sand flies. Despite efforts to prevent the spread of the disease, cases continue worldwide. In Iran, the disease usually occurs in children under 10 years. In the absence of timely diagnosis and treatment, the mortality rate is 95-100%. The main objective of this study was to determine the spatial and temporal distribution of visceral leishmaniasis as well as its correlation with climatic factors for determining high-risk areas in an endemic focus in northwestern Iran. Methods: In this cross-sectional study, data on VL cases were collected from local health centers in Ardabil Province, Iran during 2001-2015 to establish a geodatabase using ArcGIS10.3. Data analysis was conducted using SPSS23 and ArcMap Spatial Analyst. MaxEnt model was used to determine ecologically suitable nichesfor the disease. Results: Two hotspots were found in Meshkinshahr and Germi counties with 59% and 23% of total cases, respectively. There was an increase in the incidence rate of VL in Ardabil County from 2.9 in 2009 to 9.2/ 100,000 population in 2015. There was no spatial autocorrelation between county and total number of cases (P> 0.05). Higher NDVI, lower altitude and southern aspects had positive effects on the presence probability of VL. Conclusion: The number of cases of this disease have been rising since 2013 and doubled in 2015. According to the derived distribution maps, the disease is spreading to new locations such as Ardabil and Namin counties.
- 1 September 2017
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 18  (5) , e70
The use of Streptokinase for Restoration of Patency to Hemodialysis Central Venous Catheters: A Low-Cost, Safe and Effective Option
- 1 September 2017
- Published by SAGE Publications in The Journal of Vascular Access
- Vol. 18  (5) , e70
The use of Streptokinase for Restoration of Patency to Hemodialysis Central Venous Catheters: A Low-Cost, Safe and Effective Option
- Open Access
- 8 January 2017
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. In press  (In press)
Splenic Abscess Caused by Brucellosis and Its Management: A Case Report of a Rare Clinical Entity with a Brief Review of the Literature
Introduction: Brucellosis is one of the most common worldwide zoonotic and still remains endemic in many developing countries including Iran. Splenic abscess is an extremely rare complication of brucellosis. Here we describe the first reported case of splenic abscess due to brucellosis from Iran. Case Presentation: In June 2014, a 17-year-old woman was admitted to the division of infectious diseases at the Imam Khomeini hospital, Ardabil University of Medical Science, Ardabil, Iran, with complaints of fever, nausea, sweating, headache, anorexia, and abdominal pain during the previous 2 months. Abdominal computed tomography (CT) revealed hypodense lesion within the spleen. Serum antibody tested positive at a dilution of 1:1280 by the Standard Tube Agglutination test (SAT), while blood culture yielded negative results. A diagnosis of splenic abscess due to brucellosis was made and started on streptomycin plus doxycycline and rifampin for 6 weeks. Two days after the initiation of the treatment, hemophagocytic syndrome occurred, which was controlled by oral prednisone. She was followed up in the outpatient department and was given further oral antibiotic treatment. After 2 months of treatment, CT results showed complete resolution of splenic abscess. Conclusions: Splenic abscess due to brucellosis should be considered in differential diagnosis of patients who have complaints such as fever, sweating, and abdominal pain. The conservative approach of using antibiotics alone without surgical intervention can be successful in the treatment of splenic abscess due to brucellosis. Keywords: Brucellosis; Abscess; Spleen; Therapeutics
- 8 January 2017
- Published by Brieflands in Archives of Clinical Infectious Diseases
- Vol. In press  (In press)
Open AccessSplenic Abscess Caused by Brucellosis and Its Management: A Case Report of a Rare Clinical Entity with a Brief Review of the Literature
Introduction: Brucellosis is one of the most common worldwide zoonotic and still remains endemic in many developing countries including Iran. Splenic abscess is an extremely rare complication of brucellosis. Here we describe the first reported case of splenic abscess due to brucellosis from Iran. Case Presentation: In June 2014, a 17-year-old woman was admitted to the division of infectious diseases at the Imam Khomeini hospital, Ardabil University of Medical Science, Ardabil, Iran, with complaints of fever, nausea, sweating, headache, anorexia, and abdominal pain during the previous 2 months. Abdominal computed tomography (CT) revealed hypodense lesion within the spleen. Serum antibody tested positive at a dilution of 1:1280 by the Standard Tube Agglutination test (SAT), while blood culture yielded negative results. A diagnosis of splenic abscess due to brucellosis was made and started on streptomycin plus doxycycline and rifampin for 6 weeks. Two days after the initiation of the treatment, hemophagocytic syndrome occurred, which was controlled by oral prednisone. She was followed up in the outpatient department and was given further oral antibiotic treatment. After 2 months of treatment, CT results showed complete resolution of splenic abscess. Conclusions: Splenic abscess due to brucellosis should be considered in differential diagnosis of patients who have complaints such as fever, sweating, and abdominal pain. The conservative approach of using antibiotics alone without surgical intervention can be successful in the treatment of splenic abscess due to brucellosis. Keywords: Brucellosis; Abscess; Spleen; Therapeutics
- Open Access
- 1 January 2017
- Published by Medknow in International Journal of Mycobacteriology
- Vol. 6  (2) , 187-190
The first report of two cases of fatal liver injury due to anti-tuberculosis drugs in the presence of alpha-1 antitrypsin deficiency
Tuberculosis (TB) is a major global health problem. Awareness of liver injury due to anti-TB therapy is vital because fulminant hepatic failure is a devastating and often fatal condition without liver transplantation. Here, we report for the first time, two patients of fatal liver injury due to anti-TB drugs in the presence of alpha-1 antitrypsin deficiency. Based on the triad of rapid loss in hepatocyte function, the onset of hepatic encephalopathy, and absence of a prior history of liver disease, the diagnosis of acute liver failure was established. Both patients had low levels of serum alpha-1 antitrypsin, consistent with alpha-1 antitrypsin deficiency. Despite aggressive medical therapy and supportive care, patients developed multi-organ failure and died. It seems measuring the serum levels of alpha 1-antitrypsin before beginning anti-TB therapies is necessary, especially when there is emphysema or bronchiectasis.
- 1 January 2017
- Published by Medknow in International Journal of Mycobacteriology
- Vol. 6  (2) , 187-190
Open AccessThe first report of two cases of fatal liver injury due to anti-tuberculosis drugs in the presence of alpha-1 antitrypsin deficiency
Tuberculosis (TB) is a major global health problem. Awareness of liver injury due to anti-TB therapy is vital because fulminant hepatic failure is a devastating and often fatal condition without liver transplantation. Here, we report for the first time, two patients of fatal liver injury due to anti-TB drugs in the presence of alpha-1 antitrypsin deficiency. Based on the triad of rapid loss in hepatocyte function, the onset of hepatic encephalopathy, and absence of a prior history of liver disease, the diagnosis of acute liver failure was established. Both patients had low levels of serum alpha-1 antitrypsin, consistent with alpha-1 antitrypsin deficiency. Despite aggressive medical therapy and supportive care, patients developed multi-organ failure and died. It seems measuring the serum levels of alpha 1-antitrypsin before beginning anti-TB therapies is necessary, especially when there is emphysema or bronchiectasis.